Aktis Oncology
MA - BostonPharmaceutical
Focus: Aktis Oncology is a Boston-based pharmaceutical company focused on targeted radiopharmaceuticals for oncology and neurology applications. The company is in early-stage clinical development with a pipeline of actinium-225-based therapeutics.
Profile data last refreshed 18h ago · AI intelligence enriched 3w ago
Open Jobs
1
Should You Work at Aktis Oncology?
AI assessmentAktis represents a speculative early-stage opportunity best suited for risk-tolerant professionals seeking deep technical involvement in radiopharmaceuticals, but with high execution risk and limited near-term hiring.
Why Work Here
- Opportunity to work on a novel modality (targeted radiopharmaceuticals) with limited competition, positioning you at the frontier of oncology innovation.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
actinium-225 AKY-1189
Urothelial Carcinoma Bladder[225Ac]Ac-AKY-1189
Urothelial Carcinoma BladderClinical Trials (1)
Help build intelligence for Aktis Oncology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.